Healthcare
Live Price
Offline$26.62
+3.06% today
1Y Change
+159.00%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 243 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tactile Systems Technology, Inc. (TCMD) is a Healthcare stock with a market cap of $520.00M and listed on NASDAQ. The stock last traded around $26.62 and up 159.0% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of +12.5%, EPS growth of +16.9%, a dividend yield of 0.0%. What stands out right now is revenue +12.5%, EPS +16.9%, free cash flow +6.0% with operating margin 8.9% and ROIC 7.5%. Valuation is more restrained than many high-expectation growth names at P/E 26.9 and price/sales 1.6. Stock Foundry combines TCMD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TCMD
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TCMD Max Drawdown
-32.13%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TCMD and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$208.1M
-15.7% YoY
FY Net Income
-$11.8M
+33.9% YoY
Free Cash Flow
$276.0K
-91.6% YoY
Revenue Growth
+12.5%
EPS Growth
+16.9%
Gross Margin
75.2%
Net Margin
5.8%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 330M | 293M | 274M | 247M | 208M |
| Gross Profit | 248M | 217M | 195M | 176M | 148M |
| Operating Income | 29M | 22M | 18M | -13M | -2M |
| EBITDA | 36M | 32M | 26M | 2M | 2M |
| Net Income | 19M | 17M | 29M | -18M | -12M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 83M | 94M | 61M | 22M | 28M |
| Total Assets | 274M | 298M | 281M | 255M | 244M |
| Total Liabilities | 55M | 81M | 88M | 134M | 116M |
| Shareholder Equity | 219M | 217M | 194M | 121M | 128M |
| Total Debt | 16M | 45M | 50M | 72M | 81M |
| Net Debt | -67M | -49M | -11M | 50M | 52M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
-49.5% YoY
Capital Expenditures
2M
-22.7% YoY
Free Cash Flow
276K
-91.6% YoY
Key ratios
Gross Margin
75.2%
Operating Margin
8.9%
Net Margin
5.8%
ROE
9.3%
Debt / Equity
0.07x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.